Revance Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Revance Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2012 to 2023.
  • Revance Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $1.71M, a 96.8% increase year-over-year.
  • Revance Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $6.89M, a 115% increase from 2022.
  • Revance Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $3.21M, a 69.1% decline from 2021.
  • Revance Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $10.4M, a 153% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.89M +$3.68M +115% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $3.21M -$7.17M -69.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $10.4M +$6.28M +153% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $4.1M +$868K +26.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $3.23M -$3.76M -53.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $6.99M +$4.47M +177% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $2.53M +$855K +51.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $1.67M -$1.66M -49.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $3.33M -$3.65M -52.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
2014 $6.98M +$498K +7.69% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $6.48M +$6.16M +1930% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $319K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.